Advanced search
Publication Cover
Vascular Health and Risk Management Volume 6, 2010 - Issue
Submit an article Journal homepage
48
Views
12
CrossRef citations to date
0
Altmetric
Review

New class of agents for treatment of hypertension: focus on direct renin inhibition

Roberto FogariDepartment of Internal Medicine and Therapeutics, University of Pavia, ItalyCorrespondence[email protected]
&
Annalisa ZoppiDepartment of Internal Medicine and Therapeutics, University of Pavia, Italy
Pages 869-882 | Published online: 01 Oct 2010

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cuie Guang, Bo Jiang, Robert D. Phillips & Franco Milani. (2012) Inhibition of renin and the (pro)renin receptor system. Blood Pressure 21:6, pages 377-385.
Read now
Helmy M Siragy. (2011) A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors. Vascular Health and Risk Management 7, pages 297-313.
Read now

Articles from other publishers (10)

Anne Pihlanto & Sari Mäkinen. 2017. Renin-Angiotensin System - Past, Present and Future. Renin-Angiotensin System - Past, Present and Future.
Parneet Kaur, Arunachalam Muthuraman & Manjinder Kaur. (2015) The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives. ACS Chemical Neuroscience 6:4, pages 508-521.
Crossref
Parneet Kaur, Arunachalam Muthuraman & Jaspreet Kaur. (2014) Ameliorative potential of angiotensin-converting enzyme inhibitor (ramipril) on chronic constriction injury of sciatic nerve induced neuropathic pain in mice. Journal of the Renin-Angiotensin-Aldosterone System 16:1, pages 103-112.
Crossref
Jamie J. Coleman & Anthony R. Cox. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 363 385 .
Benjamin J. Epstein, Niren K. Shah & Nancy L. Borja-Hart. (2013) Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease 7:5, pages 246-259.
Crossref
Joel M. Neutel & David H. G. Smith. (2013) Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action. Cardiovascular Therapeutics 31:5, pages 251-258.
Crossref
Sergio Volman, Fernando Nicolas Benitez, Harold Cedenio, Mariano Giorgi, Nicolas Jaramillo, Nelys Molina & Judith Zilberman. (2013) Use of aliskiren in Latin America in a real-world setting: Aliskiren in Latin America Study (ALAS). Therapeutic Advances in Cardiovascular Disease 7:4, pages 189-196.
Crossref
Cuie Guang, Robert D. Phillips, Bo Jiang & Franco Milani. (2012) Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system. Archives of Cardiovascular Diseases 105:6-7, pages 373-385.
Crossref
Vicente Giner Galvañ, Josep Redón i Mas & Antonio Coca. (2011) Inhibición directa de la renina y enfermedad cardiovascular. Más allá de la hipertensión. Revista Española de Cardiología Suplementos 11, pages 25-36.
Crossref
Antonio Coca & Javier Díez. (2011) Introducción. Revista Española de Cardiología Suplementos 11, pages 1-2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.